BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36848984)

  • 1. In vitro differentiation of myeloid suppressor cells (MDSC-like) from an immature myelomonocytic precursor THP-1.
    Varela VA; da Silva Heinen LB; Marti LC; Caraciolo VB; Datoguia TS; Amano MT; Pereira WO
    J Immunol Methods; 2023 Apr; 515():113441. PubMed ID: 36848984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
    Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
    Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of myeloid-derived suppressor cell differentiation ex vivo.
    Blanco E; Escors D; Kochan G
    Methods Cell Biol; 2024; 184():85-96. PubMed ID: 38555160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
    Lechner MG; Liebertz DJ; Epstein AL
    J Immunol; 2010 Aug; 185(4):2273-84. PubMed ID: 20644162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels.
    Priceputu E; Cool M; Bouchard N; Caceres-Cortes JR; Lowell CA; Hanna Z; Jolicoeur P
    J Virol; 2021 Aug; 95(17):e0047121. PubMed ID: 34106001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
    Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
    Front Immunol; 2019; 10():183. PubMed ID: 30863394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
    Wang L; Hu D; Xie B; Xie L
    Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
    Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
    J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.
    Lee CR; Lee W; Cho SK; Park SG
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.
    Mace TA; Ameen Z; Collins A; Wojcik S; Mair M; Young GS; Fuchs JR; Eubank TD; Frankel WL; Bekaii-Saab T; Bloomston M; Lesinski GB
    Cancer Res; 2013 May; 73(10):3007-18. PubMed ID: 23514705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive role of CD11b
    Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW
    Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets.
    Tomić S; Joksimović B; Bekić M; Vasiljević M; Milanović M; Čolić M; Vučević D
    Front Immunol; 2019; 10():475. PubMed ID: 30936876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An In Vivo Mouse Model for Chronic Inflammation-Induced Immune Suppression: A "Factory" for Myeloid-Derived Suppressor Cells (MDSCs).
    Ben-Meir K; Twaik N; Meirow Y; Baniyash M
    Curr Protoc; 2022 Sep; 2(10):e558. PubMed ID: 36239438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro].
    Su Z; Zhang Y; Ni P; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1362-1365. PubMed ID: 27667463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
    Karin N
    Front Immunol; 2020; 11():557586. PubMed ID: 33193327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF promotes alloregulatory function of MDSCs through a c-Kit dependent mechanism.
    Lee YS; Saxena V; Bromberg JS; Scalea JR
    Cell Immunol; 2021 Jun; 364():104346. PubMed ID: 33848847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
    Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment.
    Pilatova K; Bencsikova B; Demlova R; Valik D; Zdrazilova-Dubska L
    Cancer Immunol Immunother; 2018 Dec; 67(12):1919-1929. PubMed ID: 29748897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.